Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
E., Giordano, G
However, many of these inhibitors, such as RSL3 and ML162, have exhibited suboptimal pharmacological properties in preclinical animal models, while others like BSO and auranofin have not yielded the desired anti-cancer effects in clinical trials, limiting their potential for clinical translation or application
Telomere attrition in neurodegenerative disorders
Global Reach: Trusted by 4,000+ clients, including nutraceutical OEM manufacturers, clinical formulators, and supplement companies across the USA, UK, EU, and other countries
This promotes faster healing and reduces inflammation
30 days (reconstituted) Mechanism Classification Primary Mechanism: NNMT (Nicotinamide N-methyltransferase) Inhibitor Target Enzyme: Nicotinamide N-methyltransferase Cellular Effect: Increases intracellular NAD+ and SAM levels Metabolic Pathway: NAD+ salvage pathway modulation Selectivity: Highly selective for NNMT (no cross-reactivity with related enzymes) Pharmacological Properties Route of Administration: Subcutaneous injection Bioavailability: High (subcutaneous)
US$ 29.04
US$ 21.78
US$ 20.39
US$ 29.67
US$ 20.88
